• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by IonQ Inc.

    6/9/25 7:05:26 AM ET
    $IONQ
    EDP Services
    Technology
    Get the next $IONQ alert in real time by email
    8-K
    false 0001824920 0001824920 2025-06-09 2025-06-09 0001824920 ionq:CommonStockParValue0.0001PerShareMember 2025-06-09 2025-06-09 0001824920 ionq:WarrantsEachExercisableForOneShareOfCommonStockFor11.50PerShareMember 2025-06-09 2025-06-09
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 9, 2025

     

     

    IonQ, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   001-39694   85-2992192

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    4505 Campus Drive    
    College Park, Maryland     20740
    (Address of Principal Executive Offices)     (Zip Code)

    Registrant’s Telephone Number, Including Area Code: 301 298-7997

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common stock, par value $0.0001 per share   IONQ   New York Stock Exchange
    Warrants, each exercisable for one share of common stock for $11.50 per share   IONQ WS   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 8.01

    Other Events.

    On June 9, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 903,195 shares of Company common stock, par value $0.0001 per share. The prospectus supplement was filed in accordance with a registration rights agreement in the form attached hereto as Exhibit 4.1. The foregoing description of the registration rights agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the form of the registration rights agreement, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference. A copy of the legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP relating to the shares covered by the prospectus supplement is filed herewith as Exhibit 5.1, and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit No.

      

    Description

    4.1    Form of Registration Rights Agreement.
    5.1    Opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP.
    23.1    Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.1).
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        IonQ, Inc.
    Date: June 9, 2025     By:  

    /s/ Stacey Giamalis

          Stacey Giamalis
          Chief Legal Officer and Corporate Secretary
    Get the next $IONQ alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IONQ

    DatePrice TargetRatingAnalyst
    12/19/2024$50.00Buy
    DA Davidson
    8/11/2023$12.00 → $21.00Buy
    Craig Hallum
    4/26/2023$7.00Equal-Weight
    Morgan Stanley
    6/8/2022$9.00Buy
    Needham
    12/17/2021$28.00 → $22.00Neutral
    Goldman Sachs
    11/22/2021$28.00Neutral
    Goldman Sachs
    More analyst ratings